Sobre la Empresa
- Nombre legal: Croda pharma
- País de registro: United Kingdom
- Dirección: Cowick, Snaith, East Cowick, Goole
- Número de empleados: 1000 - 4999
Descripción:
Croda Pharma is a leading partner for developing excipients and supplying high-purity materials for pharmaceutical formulations, offering high-purity excipients that enhance delivery, efficacy and stability of active ingredients, along with high-performing vaccine adjuvants and in-house formulation expertise to navigate drug and vaccine formulation challenges. The company focuses on enabling biologics drug delivery through its adjuvant systems and small molecule, protein and nucleic acid delivery platforms, offering solutions for both human and animal health markets backed by substantial investment in GMP and multi-site EXCiPACT accreditation.
Actividades Comerciales
Excipientes y Aditivos
FabricanteFabricante por Contrato (CMO)Proveedor de Excipientes
Extractos Naturales e Ingredientes Botánicos
FabricanteFabricante por Contrato (CMO)Proveedor de Excipientes
Químicos Farmacéuticos
FabricanteFabricante por Contrato (CMO)Proveedor de Excipientes
Mercados de Venta
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Melanesia: Papua New Guinea
- Western Asia: United Arab Emirates, Armenia, Azerbaijan
Productos/Servicios Clave
- Servicios de contratación y externalización: Adjuvant Systems for Vaccines
- Excipientes y Aditivos: Excipient: Super Refined™ PEG 400, Excipient: Super Refined™ Polysorbate 80, Excipient: Super Refined™ Polysorbate 20, Excipient: Super Refined™ DEGEE, Excipient: Super Refined™ P35 Caster Oil, Tween™ 80 HP, Super Refined™ PGML, Cholesterol, Crodafos™ CES pharma, Super Refined™ GMCC, Super Refined™ L18 POG, Super Refined™ O18 POG, Excipients for Consumer Health, Super Refined™ Benzyl Alcohol, Super Refined™ DMI, Super Refined™ GTCC, Super Refined™ PEG 300
- Químicos Farmacéuticos: Nucleic Acid Delivery for Vaccines and Next-Gen Therapeutics
- Productos Biofarmacéuticos: Cationic Adjuvant Formulation CAF®
- Servicios Biofarmacéuticos: Bioprocessing solutions and excipients for protein therapeutic formulations
- Clasificación ATC (Anatómica, Terapéutica, Química): ALC-0315
- IFA de Marca Original: ENT-DSPC, Vaccine Adjuvant: Alhydrogel™, Vaccine Adjuvant: Quil-A™
Nuestros Productos & Servicios
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Certifications
GMP
Proofs
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
Calificaciones
(0)
(0)
(0)
(0)
(0)
Comentarios
Filtros:
Ordenar por:
No hay comentarios disponibles.
Deja tu valoración & comentario